Results 11 to 20 of about 178,986 (267)

Violence Against Health Care Workers: A Silent Problem [PDF]

open access: yesTaṣvīr-i salāmat, 2012
Background and objectives: Considering the importance of process improvement and support system,we tried to take a step to clarify logistics processes and initiate quality improvement in health and nutrition faculty of Tabriz Medical Science University ...
Vahideh Ghorbani sani   +2 more
doaj  

Medication errors in Najran, Saudi Arabia: Reporting, responsibility, and characteristics: A cross-sectional study

open access: yesSaudi Pharmaceutical Journal, 2022
Background: Medication error is a preventable adverse effect of medical care, whether or not it is evident or harmful to the patient. Disclosure of medication errors and improvement of patient safety are inexorably related, and they provide one of the ...
Mohammad H. Alyami   +5 more
doaj   +1 more source

Assessment of Medication Errors at King Khalid Hospital in Hail Region, Saudi Arabia

open access: yesHail Journal of Health Sciences, 2021
Background: Medication errors (MEs) are one of the common types of medical errors that have a significant effect on a patient’s health and contribute to mortality and morbidity.
Mhdia Elhadi Osman   +6 more
doaj   +1 more source

Medication Reconciliation at Discharge from Hospital: A Systematic Review of the Quantitative Literature

open access: yesPharmacy, 2015
Medicines reconciliation is a way to identify and act on discrepancies in patients’ medical histories and it is found to play a key role in patient safety.
Maja H. Michaelsen   +3 more
doaj   +1 more source

ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS

open access: yesБезопасность и риск фармакотерапии, 2022
In this article authors analyze the influence of a label on drugpackage on the risk of medication errors and propose methods of their prevention.Analysis of the corresponding data published by regulators EMA and FDA hasprovided an opportunity to find ...
R. N. Alyautdin   +3 more
doaj  

Medication error awareness among health care providers in Palestine: A questionnaire-based cross-sectional observational study

open access: yesSaudi Pharmaceutical Journal, 2022
Background: Increased awareness among healthcare professionals regarding medication errors and the establishment of a medication error reporting system can significantly reduce the prevalence of medication errors.
Abdallah Damin Abukhalil   +3 more
doaj   +1 more source

Single cis‐elements in brassinosteroid‐induced upregulated genes are insufficient to recruit both redox states of the BIL1/BZR1 DNA‐binding domain

open access: yesFEBS Letters, EarlyView.
Phytohormone brassinosteroid‐induced gene regulation by the transcription factor BIL1/BZR1 involves redox‐dependent DNA‐binding alternation and interaction with the transcription factor PIF4. The reduced BIL1/BZR1 dimer binds preferred cis‐elements, while oxidation alters its oligomerization state and disrupts DNA‐binding ability.
Shohei Nosaki   +4 more
wiley   +1 more source

Mechanistic basis for inhibition of the extended‐spectrum β‐lactamase GES‐1 by enmetazobactam and tazobactam

open access: yesFEBS Letters, EarlyView.
Antimicrobial resistance (AMR) is of huge importance, resulting in over 1 million deaths each year. Here, we describe how a new drug, enmetazobactam, designed to help fight resistant bacterial diseases, inhibits a key enzyme (GES‐1) responsible for AMR. Our data show it is a more potent inhibitor than the related tazobactam, with high‐level computation
Michael Beer   +10 more
wiley   +1 more source

MEDICATION ERRORS: A PROSPECTIVE STUDY IN MOHAMED V MILITARY TEACHING HOSPITAL, RABAT, MOROCCO

open access: yesJournal of Community Medicine and Public Health Research, 2022
Medication errors (MEs) are preventable events that may cause or lead to inappropriate medication use or patient harm. Annually 98,000 patients die because of avoidable MEs, and it is considered a financial burden on public health organizations.
Youssef Moutaouakkil   +6 more
doaj   +1 more source

Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells

open access: yesFEBS Letters, EarlyView.
Imeglimin, at clinically relevant concentrations, inhibits vesicular ATP accumulation and release from hepatic stellate cells, thereby attenuating purinergic signaling and reducing fibrogenic activation. This mechanism reveals a newly identified antifibrotic action of imeglimin beyond glycemic control.
Seiji Nomura   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy